

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 9.94598685 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 9.03132325 |
| 3 | glomerular filtration (GO:0003094) | 7.71385562 |
| 4 | protein activation cascade (GO:0072376) | 7.35562131 |
| 5 | renal filtration (GO:0097205) | 6.96908341 |
| 6 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.18497705 |
| 7 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.18497705 |
| 8 | Fc-gamma receptor signaling pathway (GO:0038094) | 6.18497705 |
| 9 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.15405662 |
| 10 | regulation of respiratory burst (GO:0060263) | 5.95044064 |
| 11 | humoral immune response (GO:0006959) | 5.49344361 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39989849 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.35904588 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02975962 |
| 15 | antibacterial humoral response (GO:0019731) | 4.94435815 |
| 16 | antimicrobial humoral response (GO:0019730) | 4.86643608 |
| 17 | regulation of cellular extravasation (GO:0002691) | 4.68128092 |
| 18 | retina homeostasis (GO:0001895) | 4.49299194 |
| 19 | negative regulation of myotube differentiation (GO:0010832) | 4.16555247 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89556097 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.82648938 |
| 22 | germinal center formation (GO:0002467) | 3.66311425 |
| 23 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.62676142 |
| 24 | chronic inflammatory response (GO:0002544) | 3.60328920 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37205599 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.37205599 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.36385753 |
| 28 | regulation of integrin activation (GO:0033623) | 3.30910837 |
| 29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28402872 |
| 30 | regulation of antigen processing and presentation (GO:0002577) | 3.18600083 |
| 31 | eosinophil chemotaxis (GO:0048245) | 3.17530704 |
| 32 | dendritic cell chemotaxis (GO:0002407) | 3.12062847 |
| 33 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.11930512 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11101971 |
| 35 | positive regulation of pseudopodium assembly (GO:0031274) | 3.10333627 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.09677192 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.09677192 |
| 38 | response to type I interferon (GO:0034340) | 3.06378075 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.99637928 |
| 40 | protein-chromophore linkage (GO:0018298) | 2.96250804 |
| 41 | detection of other organism (GO:0098543) | 2.94414039 |
| 42 | detection of bacterium (GO:0016045) | 2.92783967 |
| 43 | positive regulation of response to oxidative stress (GO:1902884) | 2.92312037 |
| 44 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.92312037 |
| 45 | oligosaccharide biosynthetic process (GO:0009312) | 2.85687962 |
| 46 | eosinophil migration (GO:0072677) | 2.85095549 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80108577 |
| 48 | negative regulation of complement activation (GO:0045916) | 2.78856259 |
| 49 | production of molecular mediator of immune response (GO:0002440) | 2.78685040 |
| 50 | negative regulation of bone resorption (GO:0045779) | 2.75977872 |
| 51 | regulation of pseudopodium assembly (GO:0031272) | 2.75001079 |
| 52 | immune response-activating signal transduction (GO:0002757) | 2.74837500 |
| 53 | surfactant homeostasis (GO:0043129) | 2.74001007 |
| 54 | activation of immune response (GO:0002253) | 2.70673718 |
| 55 | cellular response to interferon-gamma (GO:0071346) | 2.70585528 |
| 56 | dendritic cell migration (GO:0036336) | 2.70518009 |
| 57 | wound healing, spreading of epidermal cells (GO:0035313) | 2.67528251 |
| 58 | respiratory burst (GO:0045730) | 2.65366808 |
| 59 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.64811181 |
| 60 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.63213086 |
| 61 | negative regulation of anoikis (GO:2000811) | 2.62746589 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 2.62030487 |
| 63 | response to interferon-gamma (GO:0034341) | 2.60991587 |
| 64 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.60096375 |
| 65 | negative regulation of humoral immune response (GO:0002921) | 2.57062847 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 2.54891936 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 2.52095805 |
| 68 | Golgi transport vesicle coating (GO:0048200) | 2.52095805 |
| 69 | B cell mediated immunity (GO:0019724) | 2.51853053 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 2.46846141 |
| 71 | positive regulation of macrophage differentiation (GO:0045651) | 2.46381886 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 2.43857304 |
| 73 | negative regulation of protein activation cascade (GO:2000258) | 2.43710454 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.42371860 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.40054309 |
| 76 | peptide catabolic process (GO:0043171) | 2.39791548 |
| 77 | positive regulation of T cell migration (GO:2000406) | 2.38470137 |
| 78 | interferon-gamma secretion (GO:0072643) | 2.35409187 |
| 79 | lymph node development (GO:0048535) | 2.34907125 |
| 80 | detection of external biotic stimulus (GO:0098581) | 2.34539160 |
| 81 | regulation of T cell migration (GO:2000404) | 2.34485807 |
| 82 | regulation of necrotic cell death (GO:0010939) | 2.33836094 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33089362 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 2.33016479 |
| 85 | virion attachment to host cell (GO:0019062) | 2.32165195 |
| 86 | adhesion of symbiont to host cell (GO:0044650) | 2.32165195 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.31726166 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 2.31135085 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31123651 |
| 90 | angiotensin maturation (GO:0002003) | 2.29903710 |
| 91 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.29788114 |
| 92 | regulation of vitamin metabolic process (GO:0030656) | 2.29158334 |
| 93 | O-glycan processing (GO:0016266) | 2.28530998 |
| 94 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.26610749 |
| 95 | Fc receptor signaling pathway (GO:0038093) | 2.24426867 |
| 96 | positive regulation of type 2 immune response (GO:0002830) | 2.23869995 |
| 97 | GDP-mannose metabolic process (GO:0019673) | 2.23391342 |
| 98 | response to interleukin-15 (GO:0070672) | 2.22239932 |
| 99 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.22110734 |
| 100 | complement activation, classical pathway (GO:0006958) | 12.5776807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.31260935 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.28851838 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53454437 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.31377682 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.24304739 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06236029 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.78761109 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.64098055 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.56911189 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37454577 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36032931 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27572812 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19359844 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02053939 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.91921589 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.89794887 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86086173 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84377888 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.83248521 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80227203 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77946666 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76650970 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73467959 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73433561 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71751647 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69808470 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67170823 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65322252 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62422893 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61094134 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58920658 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54665634 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50546504 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48735624 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.45350662 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43133744 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42253038 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.41416402 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34462224 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31238322 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30638085 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27834825 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26695162 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.26445171 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24303071 |
| 46 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24086347 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.23354795 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22162147 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20876733 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20074817 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18389032 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17885838 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16838184 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15200494 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14998902 |
| 56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13755532 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12182308 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11571611 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11297377 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11071710 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10374464 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10214178 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10144571 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09490439 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09117720 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07030576 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05903856 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05720669 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04566100 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02634816 |
| 71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01942792 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98811638 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98796377 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 0.98761052 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98504309 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98495976 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96575785 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94864564 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94780365 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 0.93376482 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92799546 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92731860 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92438675 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92215742 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90584022 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90552436 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89839718 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89785769 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89372697 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89366113 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88619481 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88484951 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88269891 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88120484 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86316780 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84963854 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84735796 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82155944 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81795018 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81505165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.70443437 |
| 2 | MP0003303_peritoneal_inflammation | 3.84902317 |
| 3 | MP0003436_decreased_susceptibility_to | 3.08426285 |
| 4 | MP0010155_abnormal_intestine_physiology | 2.98674247 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.97734615 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.97309179 |
| 7 | MP0001790_abnormal_immune_system | 2.64451231 |
| 8 | MP0005387_immune_system_phenotype | 2.64451231 |
| 9 | MP0005025_abnormal_response_to | 2.41808174 |
| 10 | MP0001800_abnormal_humoral_immune | 2.41741271 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 2.34584884 |
| 12 | MP0005166_decreased_susceptibility_to | 2.30128810 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.26509583 |
| 14 | MP0009785_altered_susceptibility_to | 2.25092758 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.23622427 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.15261140 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.14868775 |
| 18 | MP0003866_abnormal_defecation | 2.11772901 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.09585152 |
| 20 | MP0000685_abnormal_immune_system | 2.09523552 |
| 21 | MP0005671_abnormal_response_to | 2.06968359 |
| 22 | MP0001873_stomach_inflammation | 2.00547605 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 2.00446284 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.92246748 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.91786484 |
| 26 | MP0002419_abnormal_innate_immunity | 1.86714352 |
| 27 | MP0008004_abnormal_stomach_pH | 1.81891922 |
| 28 | MP0002723_abnormal_immune_serum | 1.77539334 |
| 29 | MP0001663_abnormal_digestive_system | 1.76309558 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.75672642 |
| 31 | MP0001819_abnormal_immune_cell | 1.71854577 |
| 32 | MP0005275_abnormal_skin_tensile | 1.70878978 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.70199568 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.69481848 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.66768369 |
| 36 | MP0006082_CNS_inflammation | 1.66079002 |
| 37 | MP0004858_abnormal_nervous_system | 1.65964896 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.64051961 |
| 39 | MP0005023_abnormal_wound_healing | 1.59341199 |
| 40 | MP0004947_skin_inflammation | 1.58023577 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.57372223 |
| 42 | MP0005310_abnormal_salivary_gland | 1.51182900 |
| 43 | MP0003279_aneurysm | 1.50814572 |
| 44 | MP0003448_altered_tumor_morphology | 1.50208126 |
| 45 | MP0003075_altered_response_to | 1.44124945 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.40603640 |
| 47 | MP0000343_altered_response_to | 1.38234751 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.33701214 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.31523037 |
| 50 | MP0000604_amyloidosis | 1.30665426 |
| 51 | MP0005381_digestive/alimentary_phenotyp | 1.30513088 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.23704301 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.23573615 |
| 54 | MP0003329_amyloid_beta_deposits | 1.23265956 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.23180129 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.22980985 |
| 57 | MP0003045_fibrosis | 1.19139261 |
| 58 | MP0000716_abnormal_immune_system | 1.19052083 |
| 59 | MP0002933_joint_inflammation | 1.18738583 |
| 60 | MP0001542_abnormal_bone_strength | 1.18411932 |
| 61 | MP0000477_abnormal_intestine_morphology | 1.17851352 |
| 62 | MP0002006_tumorigenesis | 1.14645407 |
| 63 | MP0005390_skeleton_phenotype | 1.14306084 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.13459833 |
| 65 | MP0000858_altered_metastatic_potential | 1.11871428 |
| 66 | MP0000490_abnormal_crypts_of | 1.11756956 |
| 67 | MP0002398_abnormal_bone_marrow | 1.10994849 |
| 68 | MP0001851_eye_inflammation | 1.10463200 |
| 69 | MP0002405_respiratory_system_inflammati | 1.09069541 |
| 70 | MP0001664_abnormal_digestion | 1.08080476 |
| 71 | MP0009764_decreased_sensitivity_to | 1.06211227 |
| 72 | MP0005165_increased_susceptibility_to | 1.04891314 |
| 73 | MP0005164_abnormal_response_to | 1.01647276 |
| 74 | MP0003828_pulmonary_edema | 1.00039579 |
| 75 | MP0008469_abnormal_protein_level | 0.99528570 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 0.99090959 |
| 77 | MP0002896_abnormal_bone_mineralization | 0.97589954 |
| 78 | MP0000249_abnormal_blood_vessel | 0.97073279 |
| 79 | MP0000681_abnormal_thyroid_gland | 0.96152581 |
| 80 | MP0001666_abnormal_nutrient_absorption | 0.93814464 |
| 81 | MP0002429_abnormal_blood_cell | 0.93382861 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.93117990 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.93005635 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.92515117 |
| 85 | MP0009840_abnormal_foam_cell | 0.91115391 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.90153422 |
| 87 | MP0003868_abnormal_feces_composition | 0.90128897 |
| 88 | MP0003795_abnormal_bone_structure | 0.89750447 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.85148316 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.83990115 |
| 91 | MP0004510_myositis | 0.83948801 |
| 92 | MP0002133_abnormal_respiratory_system | 0.83269505 |
| 93 | MP0005388_respiratory_system_phenotype | 0.83269505 |
| 94 | MP0002722_abnormal_immune_system | 0.80399985 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.78862004 |
| 96 | MP0002796_impaired_skin_barrier | 0.77061616 |
| 97 | MP0003091_abnormal_cell_migration | 0.76964071 |
| 98 | MP0005365_abnormal_bile_salt | 0.76666886 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.76219436 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.75499130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 8.15661369 |
| 2 | Abnormality of macrophages (HP:0004311) | 6.03426420 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.92817806 |
| 4 | Abnormality of the prostate (HP:0008775) | 5.23680027 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.24093149 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 4.03428596 |
| 7 | Vasculitis (HP:0002633) | 4.01406543 |
| 8 | Malnutrition (HP:0004395) | 3.88731923 |
| 9 | Abnormality of complement system (HP:0005339) | 3.79970329 |
| 10 | Leukocytosis (HP:0001974) | 3.62889425 |
| 11 | Glomerulonephritis (HP:0000099) | 3.62171755 |
| 12 | Complement deficiency (HP:0004431) | 3.57556678 |
| 13 | Spontaneous hematomas (HP:0007420) | 3.50998098 |
| 14 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.42158851 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.18624073 |
| 16 | Abnormality of male internal genitalia (HP:0000022) | 3.13863734 |
| 17 | Nephritis (HP:0000123) | 3.13182858 |
| 18 | Skin rash (HP:0000988) | 3.06518410 |
| 19 | Decreased circulating renin level (HP:0003351) | 2.94308505 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.89517567 |
| 21 | Premature loss of primary teeth (HP:0006323) | 2.89138593 |
| 22 | Agammaglobulinemia (HP:0004432) | 2.85626709 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 2.83895000 |
| 24 | Neoplasm of the lung (HP:0100526) | 2.82893999 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 2.77504292 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 2.74312214 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 2.69405706 |
| 28 | Colitis (HP:0002583) | 2.61014472 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.57727597 |
| 30 | Purpura (HP:0000979) | 2.57516237 |
| 31 | Myositis (HP:0100614) | 2.55874414 |
| 32 | Meningitis (HP:0001287) | 2.55146231 |
| 33 | Osteomyelitis (HP:0002754) | 2.54821808 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.53730080 |
| 35 | Gingivitis (HP:0000230) | 2.50114189 |
| 36 | Chronic otitis media (HP:0000389) | 2.49543186 |
| 37 | Cellulitis (HP:0100658) | 2.48733213 |
| 38 | Abnormality of renin-angiotensin system (HP:0000847) | 2.47534804 |
| 39 | Orchitis (HP:0100796) | 2.45214721 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44787373 |
| 41 | Hemoptysis (HP:0002105) | 2.44007138 |
| 42 | Neoplasm of the respiratory system (HP:0100606) | 2.42345361 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.40335135 |
| 44 | Chronic diarrhea (HP:0002028) | 2.39647834 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.39515036 |
| 46 | Urticaria (HP:0001025) | 2.36270871 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.34897069 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34158340 |
| 49 | Gingival bleeding (HP:0000225) | 2.32351492 |
| 50 | Bronchitis (HP:0012387) | 2.23327726 |
| 51 | Increased IgE level (HP:0003212) | 2.22760018 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.21560576 |
| 53 | Ankyloglossia (HP:0010296) | 2.21038980 |
| 54 | Hematochezia (HP:0002573) | 2.20845683 |
| 55 | Metabolic alkalosis (HP:0200114) | 2.20712483 |
| 56 | Obstructive lung disease (HP:0006536) | 2.20386642 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20386642 |
| 58 | Polycythemia (HP:0001901) | 2.17006951 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.16887153 |
| 60 | Flat acetabular roof (HP:0003180) | 2.15843054 |
| 61 | Villous atrophy (HP:0011473) | 2.13613972 |
| 62 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.13613972 |
| 63 | Fragile skin (HP:0001030) | 2.13394376 |
| 64 | Increased IgM level (HP:0003496) | 2.13230485 |
| 65 | Hypermelanotic macule (HP:0001034) | 2.12118929 |
| 66 | Recurrent viral infections (HP:0004429) | 2.12095247 |
| 67 | Alkalosis (HP:0001948) | 2.09921876 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08666592 |
| 69 | Epistaxis (HP:0000421) | 2.07017503 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.06557003 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05802804 |
| 72 | Optic neuritis (HP:0100653) | 2.05193374 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 2.05193374 |
| 74 | Emphysema (HP:0002097) | 2.03128069 |
| 75 | Periodontitis (HP:0000704) | 2.02132057 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.01365232 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 1.99086947 |
| 78 | Ileus (HP:0002595) | 1.97929894 |
| 79 | Abnormality of chloride homeostasis (HP:0011422) | 1.97528592 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 1.95788616 |
| 81 | Recurrent fungal infections (HP:0002841) | 1.94007828 |
| 82 | Conjunctival telangiectasia (HP:0000524) | 1.93953109 |
| 83 | Peritonitis (HP:0002586) | 1.93711359 |
| 84 | Abnormality of T cell number (HP:0011839) | 1.93500973 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92405964 |
| 86 | Recurrent skin infections (HP:0001581) | 1.91662968 |
| 87 | Metaphyseal cupping (HP:0003021) | 1.91269330 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 1.89008184 |
| 89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89008184 |
| 90 | Prolonged bleeding time (HP:0003010) | 1.88867269 |
| 91 | Nasal polyposis (HP:0100582) | 1.85897118 |
| 92 | Chest pain (HP:0100749) | 1.85740264 |
| 93 | Hyperaldosteronism (HP:0000859) | 1.83866917 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.83644924 |
| 95 | Atrophic scars (HP:0001075) | 1.82508204 |
| 96 | Flattened epiphyses (HP:0003071) | 1.81658609 |
| 97 | Cheilitis (HP:0100825) | 1.80916357 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 1.80268918 |
| 99 | Recurrent pneumonia (HP:0006532) | 1.79703074 |
| 100 | Restrictive lung disease (HP:0002091) | 1.79457034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.42022070 |
| 2 | TYK2 | 3.35154914 |
| 3 | MST1R | 3.07892148 |
| 4 | RIPK4 | 2.89278893 |
| 5 | RIPK1 | 2.65885389 |
| 6 | FGFR4 | 2.65774430 |
| 7 | EPHA3 | 2.49584638 |
| 8 | BLK | 2.43323307 |
| 9 | MAP4K1 | 2.32629469 |
| 10 | PRPF4B | 2.30514622 |
| 11 | EPHB1 | 2.19751912 |
| 12 | PIK3CA | 2.18390565 |
| 13 | JAK1 | 2.01461533 |
| 14 | KIT | 1.93413564 |
| 15 | JAK3 | 1.88932387 |
| 16 | ZAP70 | 1.84189532 |
| 17 | EPHA2 | 1.77330431 |
| 18 | FES | 1.73066499 |
| 19 | CSK | 1.72446661 |
| 20 | CDC42BPA | 1.70707402 |
| 21 | FGFR3 | 1.69402784 |
| 22 | MAP3K14 | 1.67444400 |
| 23 | GRK6 | 1.56188359 |
| 24 | IKBKE | 1.54261328 |
| 25 | PKN2 | 1.46439807 |
| 26 | PDGFRA | 1.45633116 |
| 27 | FER | 1.42513312 |
| 28 | JAK2 | 1.37598537 |
| 29 | EPHB2 | 1.32125115 |
| 30 | MET | 1.31604556 |
| 31 | TXK | 1.29975354 |
| 32 | IRAK4 | 1.29129732 |
| 33 | MATK | 1.28478851 |
| 34 | STK24 | 1.28210165 |
| 35 | MAP3K1 | 1.28129857 |
| 36 | DDR2 | 1.26077394 |
| 37 | SIK3 | 1.25603031 |
| 38 | IRAK1 | 1.24860083 |
| 39 | LYN | 1.24195261 |
| 40 | TBK1 | 1.22224305 |
| 41 | TGFBR2 | 1.18975607 |
| 42 | STK39 | 1.17151373 |
| 43 | SYK | 1.15680499 |
| 44 | MAP3K3 | 1.15068875 |
| 45 | ACVR1B | 1.10179552 |
| 46 | NLK | 1.08224369 |
| 47 | TAOK1 | 1.06093654 |
| 48 | LMTK2 | 1.00472821 |
| 49 | MAP3K6 | 1.00223798 |
| 50 | YES1 | 0.99758800 |
| 51 | BMPR2 | 0.99320137 |
| 52 | BTK | 0.98852001 |
| 53 | HCK | 0.98316956 |
| 54 | PDGFRB | 0.92212252 |
| 55 | CSF1R | 0.92192239 |
| 56 | RET | 0.86375107 |
| 57 | TAOK3 | 0.85975300 |
| 58 | PTK6 | 0.85747633 |
| 59 | PRKG2 | 0.85640673 |
| 60 | FGR | 0.82759456 |
| 61 | OXSR1 | 0.78655849 |
| 62 | MAP2K3 | 0.78465815 |
| 63 | MAP3K13 | 0.76215059 |
| 64 | FLT3 | 0.73612319 |
| 65 | GRK5 | 0.70970177 |
| 66 | MAP3K10 | 0.68874743 |
| 67 | KSR2 | 0.67515699 |
| 68 | LCK | 0.65731299 |
| 69 | MYLK | 0.63897759 |
| 70 | MAP3K2 | 0.60465679 |
| 71 | PDPK1 | 0.60367844 |
| 72 | FYN | 0.60096163 |
| 73 | TEC | 0.60035588 |
| 74 | ITK | 0.54976015 |
| 75 | DMPK | 0.53586607 |
| 76 | HIPK2 | 0.51963329 |
| 77 | IKBKB | 0.51813036 |
| 78 | LRRK2 | 0.51215380 |
| 79 | SMG1 | 0.51136547 |
| 80 | IGF1R | 0.51069302 |
| 81 | PDK1 | 0.48642606 |
| 82 | MAPK7 | 0.48540281 |
| 83 | IRAK3 | 0.46711591 |
| 84 | TRIB3 | 0.45856819 |
| 85 | CDK6 | 0.45597222 |
| 86 | BMX | 0.44245498 |
| 87 | TAOK2 | 0.43714214 |
| 88 | TESK2 | 0.42546308 |
| 89 | MAP3K12 | 0.41729790 |
| 90 | PAK4 | 0.37542273 |
| 91 | SRC | 0.36878572 |
| 92 | MAP2K6 | 0.36062796 |
| 93 | MAPKAPK2 | 0.35423031 |
| 94 | EIF2AK3 | 0.33785076 |
| 95 | PRKCD | 0.32991610 |
| 96 | NEK9 | 0.32532085 |
| 97 | MAP3K5 | 0.32224628 |
| 98 | GRK1 | 0.30854267 |
| 99 | ERBB2 | 0.29683208 |
| 100 | MAPK11 | 0.29111094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.78661327 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.27322616 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.84999133 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73479086 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.67838598 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65687765 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46099014 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.28060862 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14695258 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00555363 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99676811 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.91141034 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.84013392 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74632341 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68036752 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60968819 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59407773 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58168951 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57121337 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54799789 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48747160 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.48253810 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41065235 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.38723529 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37707524 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.34600187 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34547976 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31733135 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30167637 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26720262 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24170988 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20448531 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17718237 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16663584 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15494620 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11160923 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10244026 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.09019769 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.02873338 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02822610 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97963754 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96875406 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95568083 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94000887 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92461988 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 0.91614232 |
| 47 | Measles_Homo sapiens_hsa05162 | 0.90540525 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.90380568 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90244600 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87484531 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87029042 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85939134 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85787148 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85235774 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84332710 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84006608 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82961255 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74798394 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73812584 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68555961 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68207308 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67503921 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67338953 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66640197 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.65059608 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.63163255 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.61566075 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.56481057 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55069505 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54767951 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.52875124 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51441956 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49537580 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47763164 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46606858 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45366616 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44895285 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44846635 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43182817 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41927139 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41310663 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41099849 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40259351 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.40093028 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.40025600 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39361045 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38839823 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37650770 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.35242760 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34965708 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32833763 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32202523 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31653108 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30970760 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29705572 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29553237 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28858961 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28141212 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27767957 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27173132 |

